AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment of moderate-stage Parkinson’s disease in the REGENERATE-PD trial ...
Scientists are now investigating whether this seemingly immortal species could teach us how to slow down or even reverse the aging process, making it a breakthrough in anti-aging research.